中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 7
Jul.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(7): 1545-1549

Expert consensus on integrated traditional Chinese and Western medicine rehabilitation after transcatheter arterial chemoembolization for primary liver cancer

DOI: 10.3969/j.issn.1001-5256.2021.07.013
Research funding:

National Science and Technology Major Project of the Ministry of Science and Technology of China - Prevention and Treatment of Major Infectious Diseases such as AIDS and Viral Hepatitis (2018ZX10303502)

  • Received Date: 2021-05-29
  • Accepted Date: 2021-05-29
  • Published Date: 2021-07-20
    Abstract
    • FullText(HTML)
  • loading
    • References(30)
  • [1]
    ZHENG RS, SUN KX, ZHANG SW, et al. Report of cancer epidemiology in China, 2015[J]. Chin J Oncol, 2019, 41(1): 19-28. DOI: 10.3760/cma.j.issn.0253-3766.2019.01.008.

    郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 19-28. DOI: 10.3760/cma.j.issn.0253-3766.2019.01.008.
    [2]
    Bureau of Medical AdministrationNational Health Commission of the People's Republic of China. Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)[J]. J Clin Hepatol, 2020, 36(2): 277-292. DOI: 10.3969/j.issn.1001-5256.2020.02.007.

    中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J]. 临床肝胆病杂志, 2020, 36(2): 277-292. DOI: 10.3969/j.issn.1001-5256.2020.02.007.
    [3]
    LIU YY, LAI JX. Minimally invasive interventional treatment of liver cancer[J/CD]. Chin J Hepat Surg(Electronic Edition), 2020, 9(3): 201-205. DOI: 10.3877/cma.j.issn.2095-3232.2020.03.001.

    刘允怡, 赖俊雄. 肝癌微创介入治疗[J/CD]. 中华肝脏外科手术学电子杂志, 2020, 9(3): 201-205. DOI: 10.3877/cma.j.issn.2095-3232.2020.03.001.
    [4]
    HE S, XUE H. Current status and evaluation of the treatment of primary liver cancer[J]. J Hepatobiliary Surg, 2000, 8(3): 162-164. DOI: 10.3969/j.issn.1006-4761.2000.03.002.

    何生, 薛华. 原发性肝癌治疗现状与评价[J]. 肝胆外科杂志, 2000, 8(3): 162-164. DOI: 10.3969/j.issn.1006-4761.2000.03.002.
    [5]
    SCHNEEWEIβ S, HORGER M, KETELSEN D, et al. Complications after TACE in HCC - Komplikationen nach transarterieller Chemoembolisation (TACE) beim hepatozellulären Karzinom[J]. Rofo, 2015, 187(2): 79-82. DOI: 10.1055/s-0034-1369532.
    [6]
    TONGSIRI N, SUBWONGCHAROEN S, TREEPONGKARUNA SA. The impact of transarterial chemoembolization for advanced stage hepatocellular carcinoma: A single center experience[J]. J Med Assoc Thai, 2017, 100(1): 33-41. http://europepmc.org/abstract/MED/29911378
    [7]
    LIN XT, ZHANG RJ, LI FY, et al. A retrospective analysis of integrated traditional Chinese and Western medicine therapy for primary liver cancer[J]. J Chin Med Materls, 2020, 43(5): 1244-1247. DOI: 10.13863/j.issn1001-4454.2020.05.040.

    林晓彤, 张荣杰, 李福阳, 等. 中西医结合治疗原发性肝癌的回顾性研究[J]. 中药材, 2020, 43(5): 1244-1247. DOI: 10.13863/j.issn1001-4454.2020.05.040.
    [8]
    CHENG ZW, CHENG W, XING DW, et al. Progress in the application of traditional Chinese medicine in the treatment of embolism syndrome after transcatheter arterial chemoembolization[J]. Jilin J Tradit Chin Med, 2019, 39(11): 1533-1536. DOI: 10.13463/j.cnki.jlzyy.2019.11.036.

    程紫薇, 程伟, 邢东炜, 等. 中医药治疗肝动脉化疗栓塞术后栓塞综合征进展[J]. 吉林中医药, 2019, 39(11): 1533-1536. DOI: 10.13463/j.cnki.jlzyy.2019.11.036.
    [9]
    QIAN GJ, QU ZQ, CHEN H, et al. Side effects and complications of transcatheter arterial chemoembolization in treatment of liver cancer: An analysis of 1000 cases[J]. Chin J Hepatobiliary Surg, 2001, 7(1): 38-39. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHGD200101017.htm

    钱国军, 曲增强, 陈汉, 等. 肝动脉栓塞化疗术治疗肝癌的副作用和并发症(附1000例报告)[J]. 中华肝胆外科杂志, 2001, 7(1): 38-39. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHGD200101017.htm
    [10]
    KE CQ, PENG EL, PENG QP, et al. Experience of diagnosis and treatment of the complications of primary hepatocellular car-cinoma after interventional therapy[J]. Mod Oncol, 2015, 23(18): 2634-2636. DOI: 10.3969/j.issn.1672-4992.2015.18.24.

    柯传庆, 彭恩兰, 彭秋平, 等. 原发性肝癌介入术后并发症诊治经验[J]. 现代肿瘤医学, 2015, 23(18): 2634-2636. DOI: 10.3969/j.issn.1672-4992.2015.18.24.
    [11]
    LIU CJ. Clinical effect of transcatheter arterial chemoembolization combined with sequential or concurrent microwave ablation in treatment of large hepatocellular carcinoma and giant hepatocellular carcinoma[D]. Wuhan: Wuhan University, 2018.

    刘传佳. 肝动脉化疗栓塞序贯与同步联合微波消融治疗大肝癌及巨大肝癌的临床研究[D]. 武汉: 武汉大学, 2018.
    [12]
    WANG L, LU LH, ZHONG CS. Clinical effect of magnesium isoglycyrrhizinate combined with reduced glutathione in the prevention and treatment of liver damage after transcatheter arterial chemoembolization for liver cancer[J]. Chin Hepatol, 2016, 21(1): 63-65. DOI: 10.3969/j.issn.1008-1704.2016.01.019.

    王莉, 陆笼辉, 钟春生. 异甘草酸镁联合还原型谷胱甘肽防治肝癌TACE术后肝损害疗效观察[J]. 肝脏, 2016, 21(1): 63-65. DOI: 10.3969/j.issn.1008-1704.2016.01.019.
    [13]
    National Health Commission of the people's Republic of China. Guidelines for the diagnosis and treatment of cancer pain (2018 edition)[J]. Chin Clin Oncol, 2018, 23(10): 937-944. https://www.cnki.com.cn/Article/CJFDTOTAL-LCZL201810016.htm

    中华人民共和国国家卫生健康委员会. 癌症疼痛诊疗规范(2018年版)[J]. 临床肿瘤学杂志, 2018, 23(10): 937-944. https://www.cnki.com.cn/Article/CJFDTOTAL-LCZL201810016.htm
    [14]
    SWARM RA, PAICE JA, ANGHELESCU DL, et al. Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2019, 17(8): 977-1007. DOI: 10.6004/jnccn.2019.0038.
    [15]
    ZHUANG XS, LI YX, XU T, et al. Clinical features of liver abscess after interventional treatment of liver cancer and related experience in prevention and treatment[J]. Clin J Med Offic, 2015, 43(12): 1298-1299. DOI: 10.16680/j.1671-3826.2015.12.27.

    庄学山, 李奕鑫, 徐涛, 等. 肝癌介入治疗后并发肝脓肿临床特征与防治体会[J]. 临床军医杂志, 2015, 43(12): 1298-1299. DOI: 10.16680/j.1671-3826.2015.12.27.
    [16]
    Cooperative Group of Interventional Group, Chinese Society of Radiology, Chinese Medical Association. Expert consensus on technical operational standard of transcatheter arterial chemoembolization for primary hepatocellular carcinoma[J]. Chin J Radiol, 2011, 45(10): 908-912. DOI: 10.3760/cma.j.issn.1005-1201.2011.10.003.

    中华医学会放射学分会介入学组协作组. 原发性肝细胞癌经导管肝动脉化疗性栓塞治疗技术操作规范专家共识[J]. 中华放射学杂志, 2011, 45(10): 908-912. DOI: 10.3760/cma.j.issn.1005-1201.2011.10.003.
    [17]
    DHAMIJA E, PAUL SB, GAMANAGATTI SR, et al. Biliary complications of arterial chemoembolization of hepatocellular carcinoma[J]. Diagn Interv Imaging, 2015, 96(11): 1169-1175. DOI: 10.1016/j.diii.2015.06.017.
    [18]
    LUO PF, FU L, CHEN XM. Formation and clinical significance of bile tumor after interventional treatment of liver cancer[J]. Chin J Radiol, 2000, 34(11): 757. DOI: 10.3760/j.issn:1005-1201.2000.11.010.

    罗鹏飞, 符力, 陈晓明. 肝癌介入治疗后胆汁瘤的形成与临床意义[J]. 中华放射学杂志, 2000, 34(11): 757. DOI: 10.3760/j.issn:1005-1201.2000.11.010.
    [19]
    LIU YN. Value of off-bed activity in the early stage after interventional surgery in improving postoperative rehabilitation in patients with liver cancer[J]. Today Nurse, 2017, (11): 63-65. DOI: 10.3969/j.issn.1006-6411.2017.11.034.

    刘亚男. 肝癌患者介入术后早期下床活动改善术后康复的价值[J]. 当代护士(上旬刊), 2017, (11): 63-65. DOI: 10.3969/j.issn.1006-6411.2017.11.034.
    [20]
    JIANG ZQ, PAN DM. Study on adverse reactions and complications of transarterial interven-tional therapy of primary liver cancer operation and nursing[J]. Systems Med, 2017, 2(24): 122-124. DOI: 10.19368/j.cnki.2096-1782.2017.24.122.

    江芝芹, 潘冬梅. 经动脉介入治疗原发性肝癌术后不良反应及并发症的探讨与护理[J]. 系统医学, 2017, 2(24): 122-124. DOI: 10.19368/j.cnki.2096-1782.2017.24.122.
    [21]
    MA DM. Observation on the effect of air pressure treat preventing lower limbs deep vein thrombosis in paraplegic patients after surgery[J]. Clin Res, 2018, 26(10): 183-184. DOI: 10.3969/j.issn.1004-8650.2018.10.103.

    马冬苗. 气压治疗预防截瘫患者术后下肢深静脉血栓形成的效果观察[J]. 临床研究, 2018, 26(10): 183-184. DOI: 10.3969/j.issn.1004-8650.2018.10.103.
    [22]
    ZHU YE, YU JX, YI XY, et al. Effect of implementing continuing care after interventional surgery for liver cancer[J]. Int J Nurs, 2021, 40(3): 549-553. DOI: 10.3760/cma.j.cn221370-20191008-00162.

    朱英娥, 俞静娴, 裔馨颖, 等. 肝癌介入治疗术后延续性护理的实施效果[J]. 国际护理学杂志, 2021, 40(3): 549-553. DOI: 10.3760/cma.j.cn221370-20191008-00162.
    [23]
    YANG QP, LIANG J. Effect of holistic nursing intervention on urinary retention after interventional surgery for liver cancer[J]. Yunnan J Tradit Chin Med Mater Med, 2016, 37(2): 82-83. https://www.cnki.com.cn/Article/CJFDTOTAL-YZYY201602035.htm

    杨秋萍, 梁键. 整体护理干预对肝癌介入术后尿潴留的影响[J]. 云南中医中药杂志, 2016, 37(2): 82-83. https://www.cnki.com.cn/Article/CJFDTOTAL-YZYY201602035.htm
    [24]
    CHENG Z. Traditional Chinese medicine syndrome characteristics before and after transcatheter arterial chemoembolization for primary liver cancer[D]. Hangzhou: Zhejiang Chinese Medical University, 2019.

    程志. 原发性肝癌TACE介入治疗前后中医证候特点研究[D]. 杭州: 浙江中医药大学, 2019.
    [25]
    WANG D, WANG YH, LI H, et al. Clinical observation of granisetron combined with herb-separated moxibustion in the treatment of nausea and vomiting after interventional therapy for hepatocellular carcinoma[J]. Prog Mod Biomed, 2020, 20(12): 2359-2362. DOI: 10.13241/j.cnki.pmb.2020.12.035.

    王聃, 王亚华, 李辉, 等. 格拉司琼联合隔药灸治疗肝癌介入术后恶心呕吐临床观察[J]. 现代生物医学进展, 2020, 20(12): 2359-2362. DOI: 10.13241/j.cnki.pmb.2020.12.035.
    [26]
    LI H, YU Q, WANG YH, et al. Efficacy observation of herb-partitioned moxibustion combined with medication in treating nausea and vomiting after liver cancer intervention therapy[J]. Shanghai J Acupunct Moxib, 2020, 39(7): 871-874. DOI: 10.13460/j.issn.1005-0957.2020.13.1026.

    李辉, 于倩, 王亚华, 等. 隔药灸配合药物治疗肝癌介入术后恶心呕吐的疗效观察[J]. 上海针灸杂志, 2020, 39(7): 871-874. DOI: 10.13460/j.issn.1005-0957.2020.13.1026.
    [27]
    JI J, WEI GL, YIN GW, et al. Clinical observation on auricular points plaster therapy in treating adverse reaction of primary liver cancer after TACE[J]. Western J Traditl Chin Med, 2020, 33(10): 124-126. DOI: 10.12174/j.issn.1004-6852.2020.10.34.

    吉晶, 魏国利, 尹国文, 等. 耳穴压豆治疗原发性肝癌TACE术后不良反应临床观察[J]. 西部中医药, 2020, 33(10): 124-126. DOI: 10.12174/j.issn.1004-6852.2020.10.34.
    [28]
    DAI HP, YE R, HUANG SM, et al. Clinical study on auricular acupoints bean-burying therapy for hepatocellular carcinoma after interventional therapy[J]. J Clin Med Pract, 2018, 22(12): 81-83. DOI: 10.7619/jcmp.201812024.

    戴海萍, 叶然, 黄苏闽, 等. 耳穴埋籽干预肝癌介入术后疼痛的临床研究[J]. 实用临床医药杂志, 2018, 22(12): 81-83. DOI: 10.7619/jcmp.201812024.
    [29]
    GU YJ, QUAN CF, CHEN XJ. Clinical research on acupuncture combined with acupoint sticking in the treatment of stagnation of blood stasis type of cancer pain[J]. China J Chin Med, 2017, 32(12): 2307-2310. DOI: 10.16368/j.issn.1674-8999.2017.12.601.

    顾亚娇, 权春分, 陈欣菊. 针刺联合消癌痛贴治疗瘀血停滞型癌性疼痛临床研究[J]. 中医学报, 2017, 32(12): 2307-2310. DOI: 10.16368/j.issn.1674-8999.2017.12.601.
    [30]
    LIN JY. Clinical effect of wrist-ankle acupuncture in treatment of pain after interventional treatment of liver cancer: An analysis of 36 cases[J]. Shanghai J Acupunct Moxib, 2014, 33(1): 60. DOI: 10.13460/j.issn.1005-0957.2014.01.0060.

    林娟英. 腕踝针治疗肝癌介入治疗后疼痛36例[J]. 上海针灸杂志, 2014, 33(1): 60. DOI: 10.13460/j.issn.1005-0957.2014.01.0060.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (788) PDF downloads(185) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return